The cellular basis for lack of antibody response to hepatitis B vaccine in humans
- PMID: 1825504
- PMCID: PMC2118833
- DOI: 10.1084/jem.173.3.531
The cellular basis for lack of antibody response to hepatitis B vaccine in humans
Abstract
We had previously obtained evidence that among normal subjects the humoral antibody response to hepatitis B surface antigen (HBsAg) was bimodally distributed with about 14% of subjects producing less than 1,000 estimated radioimmunoassay RIA units. From the study of major histocompatibility complex (MHC) markers in the very poor responders who produced less than 36 estimated RIA units of antibody, it appeared that there was an excess of homozygotes for two extended haplotypes [HLA-B8, SC01, DR3] and [HLA-B44, FC31, DR7]. This finding suggested that a poor response was inherited as a recessive trait requiring nonresponse genes for HBsAg on both MHC haplotypes and was strengthened by finding a much lower antibody response among prospectively immunized homozygotes for [HLA-B8, SC01, DR3] compared with heterozygotes. In the present study, we have analyzed the cellular basis for nonresponse to this antigen by examining antigen-specific proliferation of T cells from responders and nonresponders in the presence and absence of autologous CD8+ (suppressor) cells. Peripheral blood cells from nonresponders to HBsAg failed to undergo a proliferative response to recombinant HBsAg in vitro, whereas cells from responders proliferated vigorously. This failure of cells from nonresponders to proliferate was not reversed in cell mixtures containing CD4+ and antigen-presenting cells devoid of CD8+ cells. There was no difference between responders and nonresponders with respect to the number of circulating T cells or their subsets, or the proliferative response to mitogens such as pokeweed or phytohemagglutinin or another antigen, tetanus toxoid. Our results indicate that our HBsAg nonresponding subjects have a very specific failure in antigen presentation or the stimulation of T helper cells, or both. Our evidence is against specific immune suppression as the basis for their nonresponsiveness. The failure of antigen presentation or T cell help is consistent with recessive inheritance of nonresponsiveness and suggests that response is dominantly inherited.
Similar articles
-
The immune response to hepatitis B vaccine in humans: inheritance patterns in families.J Exp Med. 1992 Feb 1;175(2):495-502. doi: 10.1084/jem.175.2.495. J Exp Med. 1992. PMID: 1531063 Free PMC article.
-
The human immune response to hepatitis B surface antigen.Exp Clin Immunogenet. 1995;12(3):171-81. doi: 10.1159/000424869. Exp Clin Immunogenet. 1995. PMID: 8534503 Review.
-
Nonresponders to hepatitis B vaccine can present envelope particles to T lymphocytes.J Immunol. 1995 Jan 15;154(2):520-9. J Immunol. 1995. PMID: 7814865
-
Genetic prediction of nonresponse to hepatitis B vaccine.N Engl J Med. 1989 Sep 14;321(11):708-12. doi: 10.1056/NEJM198909143211103. N Engl J Med. 1989. PMID: 2528067
-
Identification of T cell epitopes on hepatitis B surface antigen.Ann Ist Super Sanita. 1991;27(1):37-40. Ann Ist Super Sanita. 1991. PMID: 1720295 Review.
Cited by
-
Immunoprophylactic properties of the Corynebacterium pseudotuberculosis-derived MBP:PLD:CP40 fusion protein.Appl Microbiol Biotechnol. 2022 Dec;106(24):8035-8051. doi: 10.1007/s00253-022-12279-1. Epub 2022 Nov 14. Appl Microbiol Biotechnol. 2022. PMID: 36374330 Free PMC article.
-
12 Months Persistent Immunogenicity after Hepatitis B Vaccination in Patients with Type 2 Diabetes and Immunogenicity of Revaccination in Non-Responders: An Open-Label Randomized Controlled Trial.Vaccines (Basel). 2021 Nov 29;9(12):1407. doi: 10.3390/vaccines9121407. Vaccines (Basel). 2021. PMID: 34960153 Free PMC article.
-
Hepatitis B vaccine responses in a large U.S. military cohort of HIV-infected individuals: another benefit of HAART in those with preserved CD4 count.Vaccine. 2009 Jul 23;27(34):4731-8. doi: 10.1016/j.vaccine.2009.04.016. Epub 2009 May 3. Vaccine. 2009. PMID: 19540026 Free PMC article.
-
Mimicry of the a determinant of hepatitis B surface antigen by an antiidiotypic antibody. I. Evaluation in hepatitis B surface antigen responder and nonresponder strains.J Exp Med. 1993 Jan 1;177(1):127-34. doi: 10.1084/jem.177.1.127. J Exp Med. 1993. PMID: 7678109 Free PMC article.
-
Hepatitis B vaccine antibody response and the risk of clinical AIDS or death.PLoS One. 2012;7(3):e33488. doi: 10.1371/journal.pone.0033488. Epub 2012 Mar 22. PLoS One. 2012. PMID: 22457767 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials